Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT03702725

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The Ohio State University Wexner Medical Center/James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Completed

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

NCT01208766

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Canberra-CANBERRAHOSPITAL Canberra, Australia
  • AU-Melbourne-ALFRED Melbourne, Australia
  • AU-Sydney-CONCORD Sydney, Australia
View all 208 locations
View Trial Details
Completed

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01665794

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Wayne State University - Karmonos Cancer Center Detroit, Michigan, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Completed

Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

NCT02461888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Queen Elizabeth Medical Centre Birmingham, United Kingdom
  • Heart of England NHS Foundation Trust Birmingham, United Kingdom
  • Royal Bournemouth General Hospital Bournemouth, United Kingdom
  • University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom
View all 18 locations
View Trial Details

Related conditions